LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trialXue Feng, Lai Wei, Jianlong Sheng et al.|Journal of Hepatology|2024Cited by 27
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 TrialYanhang Gao, Junqi Niu, Fei Kong et al.|Clinical Infectious Diseases|2021Cited by 15
Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled TrialFeng Xue, Lai Wei, Wei Ma et al.|Clinical Gastroenterology and Hepatology|2025Cited by 2
Pradefovir in naive or experienced adult patients with chronic infection of hepatitis B virus: week24 results from 23 multicentre, double-blind, randomised, non-inferiority, phase2 trialsYanhang Gao, Junqi Niu, Fei Kong et al.|Journal of Hepatology|2020Cited by 0